Trademark: 97126771
Word
Y
Status Date
Wednesday, January 24, 2024
Filing Date
Tuesday, November 16, 2021
Published for Opposition
Tuesday, June 20, 2023
41 Business training; educational services, namely, conducting classes, seminars, conferences and webinars in the fields of oncology, immunology, infectious and metabolic diseases
5 Pharmaceuticals preparations containing biological or chemical therapeutics for use in oncology and immunology and for the treatment of infectious and metabolic diseases; medical preparations for the treatment ofneurological, oncological and immunological diseases and disorders, and dietary supplements for human beings and animals, medical plasters and fungicides for use in oncology and immunology and for the treatment of infectious and metabolic diseases; veterinary pharmaceutical preparations containing biological or chemical therapeutics for use in oncology and immunology and for the treatment of infectious and metabolic diseases; sanitary preparations for medical purposes
35 Retail and wholesale store services in the field of pharmaceutical, veterinary and sanitary preparations and medical supplies; personnel management consulting; business management and organization consultancy; retail and wholesale services by direct solicitation by sales agents in the field of oncology, immunology, infectious and metabolic diseases; import export agency services; marketing services
44 Providing medical information in the field of pharmaceutical products, medicines, vaccines, healthcare, health issues, health awareness and treatment options; On-line information services, namely, providing health information to physicians, healthcare professionals and patients on the topics of health issues, pharmaceutical products and treatments; Providing medical information via a website; providing a website featuring medical information for oncology, immunology, infectious and metabolic diseases
10 Surgical apparatus and instruments for treating various conditions related to oncology, immunology, infectious and metabolic diseases
42 Implementation of early assessment in new drug development fields to develop pharmaceutical preparations and medicines; scientific research and development; product quality testing; drug evaluation, in the nature of product quality evaluation, namely, drug discovery evaluation, drug developablity, drug efficacy, and drug metabolic kinetics for various biological or chemical therapeutics for oncology, immunology, infectious and metabolic diseases; pharmaceutical research services; biological research and analysis; technical research in the field of oncology, immunology, infectious and metabolic diseases; chemical research and analysis; bacteriological research and analysis; scientific research in the nature of conducting clinical trials for others; product research and development; scientific laboratory services
The mark consists of a stylized antibody design in the shape of the letter "Y" comprising a combination of unshaded, shaded, and half shaded circles.
Color is not claimed as a feature of the mark.
Jan 26, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2024
Sou Extension 1 Granted
Jan 24, 2024
Sou Extension 1 Filed
Jan 24, 2024
Sou Teas Extension Received
Aug 15, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 20, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 20, 2023
Published For Opposition
May 31, 2023
Notification Of Notice Of Publication E-Mailed
May 16, 2023
Approved For Pub - Principal Register
Apr 19, 2023
Examiner's Amendment Entered
Apr 19, 2023
Notification Of Examiners Amendment E-Mailed
Apr 19, 2023
Examiners Amendment E-Mailed
Apr 19, 2023
Examiners Amendment -Written
Mar 16, 2023
Notification Of Final Refusal Emailed
Mar 16, 2023
Final Refusal E-Mailed
Mar 16, 2023
Final Refusal Written
Feb 27, 2023
Teas/Email Correspondence Entered
Feb 27, 2023
Correspondence Received In Law Office
Feb 27, 2023
Teas Response To Office Action Received
Aug 26, 2022
Notification Of Non-Final Action E-Mailed
Aug 26, 2022
Non-Final Action E-Mailed
Aug 26, 2022
Non-Final Action Written
Aug 24, 2022
Assigned To Examiner
Nov 23, 2021
Notice Of Design Search Code E-Mailed
Nov 22, 2021
New Application Office Supplied Data Entered
Nov 19, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
